Fund HoldingsSarissa Capital Management LP

Total Portfolio Value
$592.42M
Total Bought
$47.84M
Total Sold
$0
Net Transaction
+$47.84M
Filing Period:
Securities
SharesValue ($K)
Q1 2024
Q2 2024
Change
Q1 2024
Q2 2024
Weight (%)
Change
CYTOKINETICS INC(CYTK)300,0001,110,000+810,00021,03360,14010.15%+39,107
BIOGEN INC(BIIB)643,000643,0000138,650149,06025.16%+10,410
NEUROCRINE BIOSCIENCES INC(NBIX)346,426410,483+64,05747,77956,5119.54%+8,732
INNOVIVA INC(INVA)7,277,0007,277,0000110,901119,34320.14%+8,441
BIOCRYST PHARMACEUTICALS INC(BCRX)1,094,1681,094,16805,5586,7621.14%+1,204
REGULUS THERAPEUTICS INC185,183185,18305333310.06%-203
VOR BIOPHARMA INC(VOR)618,000618,00001,4656180.10%-847
AMARIN CORP PLC24,850,62324,850,623022,13717,0972.89%-5,040
GILEAD SCIENCES INC(GILD)1,103,2821,103,282080,81575,69612.78%-5,119
IRONWOOD PHARMACEUTICALS INC16,390,00016,390,0000142,757106,86318.04%-35,894
Page 1 of 1